Formation of experimental murine AA amyloid fibrils in SAP-deficient mice: High resolution ultrastructural study

References

• Togashi S, Lim S -K, Kawano H, Ito S, Ishihara T, Okada Y, Nakano S, Kinoshita T, Horie K, Episkopou V, et al. Serum amyloid P component enhances induction of murine amyloidosis. Lab Invest 1997; 77: 525–531
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, Young I D. Pathogenesis of amyloidosis. Clinical rheumatology: Reactive amyloidosis and the acute phase response, G Husby. Bailliere Tindall, London 1994; 8: 613–626
   Google Scholar
• Kisilevsky R, Gruys E, Shirahama T. Does amyloid enhancing factor (AEF) exist? Is AEF a single biological entity?. Amyloid: J Protein Folding Disord 1995; 2: 128–133
   Web of Science ®Google Scholar
• Inoue S, Kisilevsky R. A high resolution ultrastructural study of experimental murine AA amyloid. Lab Invest 1996; 74: 670–683
   PubMed Web of Science ®Google Scholar
• Inoue S, Kisilevsky R. In situ electron microscopy of amyloid deposits in tissues. Methods Enzymol 1999; 309: 496–509
   PubMed Web of Science ®Google Scholar
• Inoue S, Kuroiwa M, Tan R, Kisilevsky R. A high resolution ultrastructural comparison of isolated and in situ murine AA amyloid fibrils. Amyloid: Int J Exp Clin Invest 1998; 5: 99–110
   PubMed Web of Science ®Google Scholar
• Inoue S, Kuroiwa M, Kisilevsky R. AA protein in experimental murine AA amyloid fibrils: A high resolution ultrastructural and immunohistochemical study comparing aldehyde-fixed and cryofixed tissues. Amyloid: J Protein Folding Disord 2002; 9: 115–125
   PubMed Web of Science ®Google Scholar
• Usui I, Kawano H, Ito S, Hamada Y, Ishihara T, Maeda S. Homozygous serum amyloid P component-deficiency does not enhance regression of AA amyloid deposits. Amyloid: J Protein Folding Disord 2001; 8: 101–104
   PubMed Web of Science ®Google Scholar
• Ram J S, DeLellis R A, Glenner G G. Amyloid III: A method for rapid induction of amyloidosis in mice. Int Arch Allergy 1968; 34: 201–204
   Web of Science ®Google Scholar
• Kohno K, Palha J A, Miyakawa K, Saraiva M JM, Ito S, Mabuchi T, Blaner W S, Iijima H, Tsukahara S, Episkopou V, et al. Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy. Am J Pathol 1997; 150: 1497–1508
   PubMed Web of Science ®Google Scholar
• Takeda M, Takayama I, Terada N, Baba T, Ward S M, Ohno S, Fijino M A. Immunoelectron-microscopic study of Kit-expressing cells in the jejunum of wildtype and Ws/Ws rats. Cell Tissue Res 2001; 304: 21–30
   PubMed Web of Science ®Google Scholar
• Inoue S. Ultrastructural organization of connective tissue microfibrils in the posterior chamber of the eye in vivo and in vitro. Cell Tissue Res 1995; 279: 291–302
   PubMed Web of Science ®Google Scholar
• Inoue S, Kuroiwa M, Kisilevsky R. Basement membrane, microfibrils and β-amyloid fibrillogenesis in Alzheimer's disease: high resolution ultrastructural findings. Brain Res Rev 1999; 29: 218–231
   PubMedGoogle Scholar
• Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962; 10: 355–364
   Web of Science ®Google Scholar
• Romhányi G. Selective differentiation between amyloid and connective tissue structures based on the collagen-specific topo-optical staining reaction with Congo red. Virchows Arch (Pathol Anat) 1971; 354: 209–222
   PubMedGoogle Scholar
• Wolman M, Bubis J J. The cause of the green polarization color of amyloid stained with Congo red. Histochemie 1965; 4: 351–356
   PubMedGoogle Scholar
• Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, Dobson C M. Designing conditions for in vitro formation of amyloid protofibrils and fibrils. Proc Natl Acad Sci USA 1999; 96: 3590–3594
   PubMed Web of Science ®Google Scholar
• Inoue S, Kuroiwa M, Ohashi K, Hara M, Kisilevsky R. Ultrastructural organization of hemodialysis-associated β2-microglobulin amyloid fibrils. Kidney Int 1997; 52: 1543–1549
   PubMed Web of Science ®Google Scholar
• Inoue S, Hultin P G, Szarek W A, Kisilevsky R. Effect of poly(vinylsulfonate) on murine AA amyloid: a high-resolution ultrastructural study. Lab Invest 1996; 74: 1081–1090
   PubMed Web of Science ®Google Scholar
• Pepys M B, Dyck R F, de Beer F C, Skinner M, Cohen A S. Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol 1979; 38: 284–293
   PubMed Web of Science ®Google Scholar
• Tennent G A, Lovat L B, Pepys M B. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer's disease and systemic amyloidosis. Proc Natl Acad Sci USA 1995; 92: 4299–4303
   PubMed Web of Science ®Google Scholar
• Holm E Nielsen, Nybo M, Junker K, Toftedal P Hansen, Rasmussen I M, Svehag S -E. Localization of human serum amyloid AP component and heparan sulfate proteoglycan in in vitro-formed Aβ fibrils. Scand J Immunol 2000; 52: 110–112
   PubMed Web of Science ®Google Scholar
• McCubbin W D, Kay C M, Narindrasorasak S, Kisilevsky R. Circular dichroism and fluorescence studies on two murine serum amyloid A proteins. Biochem J 1988; 256: 775–783
   PubMed Web of Science ®Google Scholar
• De Beer M C, De Beer F C, McCubbin W D, Kay C M, Kindy M S. Structural prerequisites for serum amyloid A fibril formation. J Biol Chem 1993; 268: 20606–20612
   PubMed Web of Science ®Google Scholar